Dolby Laboratories, Inc.
General ticker "DLB" information:
- Sector: Information Technology
- Industry: Information Technology Services
- Capitalization: $7.2B (TTM average)
Dolby Laboratories, Inc. does not follow the US Stock Market performance with the rate: -7.1%.
Estimated limits based on current volatility of 1.2%: low 64.48$, high 66.10$
Factors to consider:
- Company pays dividends (quarterly): last record date 2026-02-10, amount 0.36$ (Y2.20%)
- Total employees count: 2080 as of 2024
- US accounted for 35.4% of revenue in the fiscal year ended 2024-09-27
- Top business risk factors: Market trends affecting content distribution, Reputation and brand risks, Third-party risks, Supply chain disruptions, Cybersecurity threats
- Price in estimated range
- Earnings for 3 months up through Q1 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-09-26 to 2027-09-26
- 2025-09-26 to 2026-09-26 estimated range: [62.23$, 86.55$]
- 2026-09-26 to 2027-09-26 estimated range: [65.44$, 90.29$]
Financial Metrics affecting the DLB estimates:
- Negative: with PPE of 16.9 at the end of fiscal year the price was high
- Positive: Operating profit margin, % of 19.64 > 18.38
- Positive: 6.64 < Operating cash flow per share per price, % of 6.85
- Positive: Return on assets ratio (scaled to [-100,100]) of 7.36 > 6.11
- Positive: Industry inventory ratio change (median), % of 0.17 <= 0.31
- Negative: Industry operating cash flow per share per price (median), % of 2.49 <= 5.46
- Positive: Investing cash flow per share per price, % of -0.15 > -0.63
- Positive: Shareholder equity ratio, % of 81.25 > 64.29
- Positive: Inventory ratio change, % of -0.07 <= 0
Short-term DLB quotes
Long-term DLB plot with estimates
Financial data
| YTD | 2024-09-27 | 2025-09-26 |
|---|---|---|
| Operating Revenue | $1,273.72MM | $1,349.13MM |
| Operating Expenses | $1,009.01MM | $1,084.17MM |
| Operating Income | $264.71MM | $264.96MM |
| Non-Operating Income | $47.77MM | $38.53MM |
| R&D Expense | $263.66MM | $261.79MM |
| Income(Loss) | $312.48MM | $303.49MM |
| Taxes | $48.16MM | $46.99MM |
| Profit(Loss)* | $261.82MM | $255.02MM |
| Stockholders Equity | $2,477.16MM | $2,622.56MM |
| Inventory | $0.00MM | $30.42MM |
| Assets | $3,109.93MM | $3,227.76MM |
| Operating Cash Flow | $327.25MM | $472.20MM |
| Capital expenditure | $30.01MM | $41.94MM |
| Investing Cash Flow | $-286.29MM | $-10.59MM |
| Financing Cash Flow | $-287.81MM | $-247.24MM |
| Earnings Per Share** | $2.74 | $2.66 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.